Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Vanguard Industrials ETF
VIS
$8.23B
| $1.21M | ﹤0.01% |
3,883
-247
| -6% | -$80.2K |
|
|
STUB
2852
StubHub Holdings
STUB
$3.1B
| $1.21M | ﹤0.01% |
194,040
+1,204
| +0.6% | +$12.5K |
|
2853
First Business Financial Services
FBIZ
$562M
| $1.21M | ﹤0.01% |
22,373
-2,302
| -9% | -$128K |
|
2854
Southern First Bancshares
SFST
$582M
| $1.2M | ﹤0.01% |
22,075
-269
| -1% | -$14.9K |
|
2855
C4 Therapeutics
CCCC
$376M
| $1.19M | ﹤0.01% |
452,228
+2,796
| +0.6% | +$6.58K |
|
2856
Ranpak Holdings
PACK
$553M
| $1.19M | ﹤0.01% |
332,113
-29,109
| -8% | -$143K |
|
2857
InMode
INMD
$872M
| $1.18M | ﹤0.01% |
86,330
+25,124
| +41% | +$358K |
|
2858
Contango Silver & Gold Inc
CTGO
$529M
| $1.17M | ﹤0.01% |
62,284
+28,541
| +85% | +$753K |
|
2859
Colony Bankcorp
CBAN
$462M
| $1.16M | ﹤0.01% |
58,044
+7,969
| +16% | +$155K |
|
2860
Solid Biosciences
SLDB
$771M
| $1.16M | ﹤0.01% |
160,730
-807
| -0.5% | -$5.18K |
|
|
NB
2861
NioCorp Developments
NB
$603M
| $1.15M | ﹤0.01% |
258,268
-5,727
| -2% | -$32.8K |
|
2862
Gyre Therapeutics
GYRE
$662M
| $1.15M | ﹤0.01% |
165,238
-3,920
| -2% | -$30.4K |
|
2863
Strive Inc
ASST
$961M
| $1.15M | ﹤0.01% |
114,525
+96,948
| +552% | +$1.21M |
|
2864
Domo
DOMO
$166M
| $1.14M | ﹤0.01% |
373,531
-9,770
| -3% | -$49.5K |
|
2865
Compass Diversified
CODI
$755M
| $1.14M | ﹤0.01% |
145,271
-18,145
| -11% | -$116K |
|
|
OFRM
2866
Once Upon a Farm PBC
OFRM
$631M
| $1.14M | ﹤0.01% |
+69,614
| New | +$1.43M |
|
2867
Orchestra BioMed
OBIO
$224M
| $1.13M | ﹤0.01% |
265,499
+1,711
| +0.6% | +$7.28K |
|
2868
ProKidney
PROK
$308M
| $1.12M | ﹤0.01% |
627,771
+4,661
| +0.7% | +$9.89K |
|
2869
Home Bancorp
HBCP
$552M
| $1.12M | ﹤0.01% |
18,542
-1,953
| -10% | -$118K |
|
2870
KRONOS Worldwide
KRO
$761M
| $1.12M | ﹤0.01% |
170,911
-5,051
| -3% | -$28.6K |
|
|
DRUG
2871
Bright Minds Biosciences
DRUG
$700M
| $1.12M | ﹤0.01% |
15,318
+2,853
| +23% | +$230K |
|
2872
Virgin Galactic
SPCE
$320M
| $1.12M | ﹤0.01% |
458,931
+52,216
| +13% | +$142K |
|
2873
Aquestive Therapeutics
AQST
$462M
| $1.11M | ﹤0.01% |
267,419
-34,102
| -11% | -$138K |
|
2874
Citizens & Northern Corp
CZNC
$436M
| $1.1M | ﹤0.01% |
49,447
-502
| -1% | -$11.1K |
|
2875
GoodRx Holdings
GDRX
$1B
| $1.1M | ﹤0.01% |
562,636
+87,027
| +18% | +$204K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.